2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Objective Measurement in Clinical Care of Patients with Parkinson’s disease: an RCT using the PKG

P. Farzanehfar, M. Braybrook, K. Kotschet, M. Horne (Parkville, Australia)
Objective measurement of upper extremity bradykinesia using the keyboard-based dexterity test

S.-k. Song, J.-H. Kang (Jejusi, Republic of Korea)
Observational study of the effectiveness and tolerability of rotigotine+levodopa therapy in older vs younger Parkinson’s disease patients

D. Woitalla, M. Asgharnejad, L. Joeres, J.-C. Schuller, K.R. Chaudhuri (Bochum, Germany)
Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh

R. Hoque (Dhaka, Bangladesh)
Occupational trichloroethylene exposure and Parkinson’s disease risk

S. Goldman, P. Quinlan, C. Meng, K. Comyns, G.W. Ross, K. Marek, C. Tanner (San Francisco, CA, USA)
Ocular Motor Disorders Among Filipino “LUBAG” or X-Linked Dystonia Parkinsonism (XDP) Patients

M. Macas, E.C. Rossi, S. Abantas-Diamla, A. Punzalan-Sotelo, E. Palisoc, C. Go (Manila, Philippines)
Oculogyric Crisis Due to Treatment With flunarizine

M. Kurtz, D. Ballesteros, J. Crespo, J. Perez Garcia, J. Lopez, I. Lagger, F. Knorre (CF, Argentina)
Off-Target Implications of Nurr1 Agonist Therapy in Parkinson’s disease

K. Steece-Collier, T. Collier, J. Stancati, C. Kemp, B. Daley, C. Sortwell (Grand Rapids, MI, USA)
Olfaction and gustation in patients with Parkinson’s Disease

A. Tautscher-Basnett, V. Tomantschger, M. Freimueller (Hermagor, Austria)
Olfactory deficits in the cognitive impaired de novo patients with Parkinson’s disease

J.S. Baik, H.I. Ma (Seoul, Republic of Korea)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z